Company | Name | Exchange | Sector | Industry | Return on Invested Capital | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Saudi Arabia | 51.8% | SAR 694Cr | 16.3x | 0.46 | SAR 30.95 | 8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Upgrade to Pro+ | Saudi Arabia | Technology | Software & IT Services | 33.7% | SAR 27.30Cr | 13.3x | 0.25 | SAR 91.90 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Saudi Arabia | Technology | Financial Technology (Fintech) & Infrastructure | 30.9% | SAR 650Cr | 62x | 0.7 | SAR 83.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | Consumer Non-Cyclicals | Food & Tobacco | 30.8% | SAR 116Cr | 20.8x | 0.99 | SAR 24.12 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Saudi Arabia | Energy | Oil & Gas | 27.5% | SAR 6.23LCr | 15.6x | -1.21 | SAR 25.80 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.5% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | Healthcare | Pharmaceuticals | 24.6% | SAR 1.05KCr | 31.2x | 1.37 | SAR 150.60 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.8% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | Consumer Non-Cyclicals | Personal & Household Products & Services | 23.9% | SAR 309Cr | 22x | 3.52 | SAR 124 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.5% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | Industrials | Freight & Logistics Services | 22.3% | SAR 1.44KCr | 23.8x | 0.73 | SAR 179.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.6% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | Healthcare | Pharmaceuticals | 20.7% | SAR 256Cr | 32.4x | 1.52 | SAR 129 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.5% Downside | Upgrade to Pro+ |